Scientists Discover Cancer-Destroying Bacterium in Rats

Japanese researchers have discovered that Ewingella americana, a naturally occurring gut bacterium isolated from the common tree frog, can eradicate cancerous tumors in rats with a 100% response rate, according to a report by TechSpot. Led by Professor Eijiro Miyako at the Japan Advanced Institute of Science and Technology, the team found that the bacterium targets oxygen-deprived cancer cells and releases inflammatory proteins to recruit immune cells while leaving healthy organs unharmed.

How Ewingella Americana Destroys Cancer Cells in Lab Tests

The research shows that Ewingella americana attacks tumors through several complementary biological mechanisms. According to TechSpot, the bacterium accumulates in oxygen-deprived cancer cells, increasing its presence by nearly 3,000 times after just a single administration. Once positioned at the tumor site, it releases inflammatory proteins that draw T cells, B cells, and other immune defenses directly to the area.

Did you know? Researchers examined 45 different bacterial strains from Japanese tree frogs, Japanese fire-bellied newts, and Japanese grass lizards before narrowing the pool down to nine strains with antitumoral effects, with Ewingella americana ultimately standing out.

Safety Profile and Bloodstream Clearance Rates

Preclinical safety evaluations indicate that the bacterium clears rapidly from the bloodstream and does not colonize healthy tissues, according to the study findings. While administration triggers a mild inflammatory response, researchers noted that this side effect typically subsides within 72 hours. The Japanese research team is currently focusing on how the strain affects other cancer types and how to optimize administration to minimize inflammation.

Challenging Long-Standing Immune System Rules

In related immunology developments published in Nature Immunology, researchers at the Baylor College of Medicine and the University of Michigan uncovered an unexpected way T cells target diseased cells. Led by Dr. Pavan Reddy, director of the Dan L Duncan Comprehensive Cancer Center at Baylor, the team found that lowering major histocompatibility complex class I (MHC I) expression leaves tumor cells vulnerable to ferroptosis—a form of cell death driven by iron and oxidative stress—triggered by CD4+ “helper” T cells, challenging decades-old assumptions about immune division of labor.

Pro Tip: Monitoring updates in both microbial tumor targeting and MHC I regulation can provide early insights into next-generation cancer immunotherapy combinations.

Frequently Asked Questions

What bacterium did scientists discover to destroy cancer cells in rats?

Japanese researchers found that Ewingella americana, a gut bacterium isolated from the common tree frog, achieves a 100% response rate in eradicating cancerous tumors in rats, according to TechSpot.

How does Ewingella americana target tumors?

The bacterium accumulates in oxygen-deprived cancer areas—increasing its presence nearly 3,000-fold after a single administration—and releases inflammatory proteins that attract T cells and B cells to build up immune defenses.

Is the frog gut bacterium safe for administration?

Yes, the study indicates it is safe because it rapidly clears from the bloodstream without colonizing healthy tissues, though it does trigger a mild inflammatory response that subsides within 72 hours.

What did the Baylor College of Medicine study reveal about T cells?

Want to stay updated on the latest breakthroughs in biotechnology and cancer research? Subscribe to our newsletter or explore our archives for more in-depth reporting.

Leave a Comment